Home Featured Page 143

Featured

Latest

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months

CLOSING RECEPTION Travis Gillan’s Revelator

PT356 – Brom Rector – Investing in Psychedelics and The Rush...

Revive Therapeutics Provides Update on the Psilocybin Clinical Study for Methamphetamine...

Bexson Biomedical Granted USPTO Patent Allowance on Proprietary Formulation Technology, SEVALENT™

Silo Pharma Announces Implementation of 1-for-50 Reverse Stock Split in Preparation...

MindMed Announces Compliance with Nasdaq Listing Requirements

MYDECINE INNOVATIONS GROUP FILES PROSPECTUS SUPPLEMENT AND ANNOUNCES CLOSING UNDER SHARE...

Sep 13, 2022, 16:50 ETMINDCURE Announces Financial Results for Fiscal 2022VANCOUVER,...

Psilera Receives First Patent Allowance for Transdermal Patch Formulations

Revive Therapeutics Announces Submission of Amended Phase 3 COVID-19 Study Protocol...

Mindset Pharma Receives Scientific Advice from UK Regulator Facilitating Advancement of...

1...142143144...301 Page 143 of 301

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months

CLOSING RECEPTION Travis Gillan’s Revelator

PT356 – Brom Rector – Investing in Psychedelics and The Rush...

Revive Therapeutics Provides Update on the Psilocybin Clinical Study for Methamphetamine...

Bexson Biomedical Granted USPTO Patent Allowance on Proprietary Formulation Technology, SEVALENT™

Silo Pharma Announces Implementation of 1-for-50 Reverse Stock Split in Preparation...

MindMed Announces Compliance with Nasdaq Listing Requirements

MYDECINE INNOVATIONS GROUP FILES PROSPECTUS SUPPLEMENT AND ANNOUNCES CLOSING UNDER SHARE...

Sep 13, 2022, 16:50 ETMINDCURE Announces Financial Results for Fiscal 2022VANCOUVER,...

Psilera Receives First Patent Allowance for Transdermal Patch Formulations

Revive Therapeutics Announces Submission of Amended Phase 3 COVID-19 Study Protocol...

Mindset Pharma Receives Scientific Advice from UK Regulator Facilitating Advancement of...

EDITOR PICKS

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY